Synlait says Munchkin US FDA process on hold

Synlait says Munchkin US FDA process on hold
Rebecca Howard
By Rebecca Howard May 16 (BusinessDesk) - Synlait Milk said the registration process required to launch Munchkin Inc’s Grass Fed infant formula in the US has been put on hold to allow the company to look at other options.  Synlait "has been informed that the clinical study has been put on hold to allow Munchkin to explore other options in the US," it said.  Synalit chief executive Leon Clement said Munchkin has not terminated its supply agreement with Synlait. "For other markets were Grass Fed is sold, the relationship continues with b...

More Primary Sector

Westpac looks seaward to boost NZ's economy
Primary Sector

Westpac looks seaward to boost NZ's economy

A senior scientist says less red tape could transform the aquaculture industry.

Greg Hurrell 20 Feb 2025
Fonterra still looking at trade sale and IPO options
Primary Sector

Fonterra still looking at trade sale and IPO options

Fonterra says it is thoroughly testing both options. 

Rebecca Howard 19 Feb 2025
What's behind Synlait's rapid share price rise?
Primary Sector

What's behind Synlait's rapid share price rise?

The shares started the year at 40c – and have now passed $1. 

The influential Chinese reviewer testing a2 Milk
Primary Sector

The influential Chinese reviewer testing a2 Milk

'Incredibly' influential consumer advocate visited A2 factories and farms in NZ.